Susu has secured growth financing led by INCO Ventures to enhance its healthcare services in Africa's expanding market, targeting vulnerable populations with innovative insurance solutions.

Target Information

Susu is a Franco-African startup established in 2019 that specializes in delivering innovative and affordable healthcare and insurance solutions across Africa. With a rapidly growing population projected to reach 2 billion by 2050, Africa faces rising life expectancy rates alongside increasing instances of chronic conditions such as diabetes and hypertension. Susu aims to address these challenges by offering insurance products and tailored healthcare packages designed for various demographics, including seniors, individuals with chronic illnesses, and pregnant women.

The company's solutions encompass a digital platform that connects users to a wide-ranging medical network, promoting accessibility and quality healthcare. By leveraging unique financing strategies that tap into the African diaspora, Susu is well-positioned to serve both healthy individuals and vulnerable populations in need of health and insurance services.

Industry Overview in Africa

The healthcare industry in Africa is undergoing significant transformation as the continent grapples with diverse health challenges amidst rapid demographic changes. With a youthful population, the demand for modern healthcare solut

View Source

Similar Deals

New Rhein Healthcare Investors, Andera Partners, Omega Funds Alveus Therapeutics

2026

Series A Bio Therapeutic Drugs United States of America
Eli Lilly and Company Recludix Pharma

2026

Series A Proprietary & Advanced Pharmaceuticals United States of America
Odyssée Venture and GO Capital BrightHeart

2026

Series A Medical Imaging Systems France
Novalis Biotech Altavo GmbH

2026

Series A Advanced Medical Equipment & Technology (NEC) Germany

INCO Ventures

invested in

Susu

in 2023

in a Series A deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert